Prostate Cancer

Quick Reference

Open a 2-page quick reference summary of the therapies best supported by evidence for use with prostate cancer:

quick reference document

Key Points

Blue icons beneath the page title are quick links to sections of this page.

  • Conventional treatment for prostate cancer has become much less aggressive in recent decades, preserving quality of life for many men without sacrificing survival.
  • Radical surgery and/or radiation therapy are no longer standard approaches in conventional treatment for early, low-risk prostate cancer, with a shift toward watchful waiting or active surveillance.
  • Integrative therapies during a period of waiting or surveillance, and also during treatment, show significant potential benefit to patients.

Read more

Prostate cancer is a prime example of an integrative approach not only in reducing risk of primary prostate cancer, but in treating and reducing risk of progression or recurrence. Following a healthy lifestyle program during active surveillance of low-risk prostate cancer may favorably change the behavior of the cancer while at the same time improving health and quality of life. Holding the cancer in this low-risk state could mean foregoing invasive treatments such as surgery or radiation therapy—treatments that can significantly reduce quality of life.

Watchful Waiting

Watchful waiting and active surveillance are treatments used for older men who do not have signs or symptoms or have other medical conditions and for men whose prostate cancer is found during a screening test.

Read more

In the ProtecT study, for instance, men with localized prostate cancer who were followed for 10 years lived equally long whether they did active surveillance, surgery or radiation therapy. While the disease was less likely to progress in those receiving prostatectomy or radiotherapy, 44 percent of the patients who were assigned to active monitoring did not receive radical treatment and avoided side effects. Moreover, survival was as good among those who were untreated as among those who were treated—and they avoided the risks of treatment side effects.

Read more

Integrative Care in Prostate Cancer

In the ProtecT study, men with localized prostate cancer who were followed for 10 years lived just as long whether they did active surveillance, surgery or radiation therapy.

Before investigating integrative care in prostate cancer, we recommend reviewing integrative cancer care in general.

Our goal is to help you live as well as you can for as long as you can using the optimal combination of conventional, complementary and integrative therapies and approaches.

Read more

Clinical Practice Guidelines

Examples: Treatment Approaches from Noted Specialists and Practices

We note examples of prostate cancer treatment approaches used by leaders in the field. Some use minimally invasive conventional procedures with some integrative approaches, while others are more fully integrative in approach.

Aaron Katz, MD, and the Active Holistic Surveillance Program

Read more

Ornish Lifestyle Medicine

Compared to men under active surveillance who didn’t make lifestyle changes, those who followed Ornish’s program had favorable biological markers, including lower PSAs.

Read more

Charles “Snuffy” Myers, MD

Read more

Prostate Oncology Specialists

Read more

Prostate Institute of America

Read more

Block Center for Integrative Cancer Treatment

Read more

Integrative Programs, Protocols and Medical Systems

For more information about programs and protocols, see our Integrative Programs and Protocols page.

Read more

Integrative Therapies in Prostate Cancer

7 Healing Practices: The Foundation

The 7 Healing Practices listed here all promote wellness and tend to make your body terrain less hospitable to the development and progression of cancer. Some practices address cancer symptoms and side effects.

Eating Well

Read more

7 Healing Practices

Moving More

Read more

The risks from these lifestyle changes are very low, and the potential benefits are great.

Managing Stress

Read more

Sleeping Well

Read more

Creating a Healing Environment

Read more

Sharing Love and Support

Read more

Exploring What Matters Now

Read more

Other Lifestyle Associations

Obesity

Read more

Tobacco Smoking

Read more

Finding Reliable Information about Prostate Cancer

As research continues to identify best practices in prostate cancer prevention, detection and treatment, advice has changed considerably over the last couple of decades.

However, quite a lot of information that is either outdated or inaccurate is still available online and is passed along through social media.

Read more

Beyond the 7 Healing Practices: Further Integrative Therapies

Complementary therapies and lifestyle practices can be useful to enhance treatment effects, improve quality of life and possibly even extend life for those with prostate cancer.

Read more

Cells, Animals and People

Studies on human cells can be helpful in finding effects of drugs, radiation, natural compounds and other potential therapies on tumors. However, isolated cells or tissues in a highly controlled lab may behave very differently from tumors and other cells in real human beings.

Read more

Therapies are grouped according to their effects:

  • Treating the cancer
  • Managing side effects and promoting wellness
  • Reducing risk

We present natural products and off-label, overlooked and novel cancer approaches (ONCAs) in six groups:

  1. Good clinical evidence of efficacy & safety, easy access
  2. Good clinical evidence of efficacy & safety, limited access
  3. Limited clinical evidence of efficacy but good safety, used in leading integrative programs
  4. Limited clinical evidence of efficacy, or significant cautions, but potential significant benefit
  5. Especially promising preclinical evidence of efficacy and safety
  6. Evidence of no efficacy or may be dangerous

Within each section, we list only groups containing applicable therapies.

Other integrative therapies and approaches are described but not categorized. See the full summaries as linked for more information on each of these therapies.

Treating the Cancer

Predicting Treatment Outcomes

Predict Prostate is an online prognostic tool from the University of Cambridge. It uses an individualized prognostic model for men newly diagnosed with non-metastatic prostate cancer to compare the outcomes from conservative management (or monitoring) with radical treatment (surgery or radiotherapy). This tool is endorsed by the UK National Health Service (NHS) and Public Health England.

Working against cancer growth or spread, improving survival, or working with other treatments or therapies to improve their anticancer action

Conventional Prostate Cancer Therapies

Read more

Natural Products

Group 3: Limited clinical evidence of efficacy but good safety, used in leading integrative programs

Read more

Group 4: Limited clinical evidence of efficacy, or significant cautions, but potential significant benefit

May be used in leading integrative oncology programs. Therapies in this group may need more medical oversight and surveillance.

Read more

Group 5: Especially promising preclinical evidence of efficacy and safety

Other therapies with preclinical evidence only for treating the cancer

Read more

Group 6: Evidence of no efficacy or may be dangerous

Read more

Off-label, Overlooked or Novel Cancer Approaches (ONCAs)

Group 1: Good clinical evidence of efficacy & safety, easy access

These therapies may be widely used in integrative cancer protocols and traditional medical systems.

Read more

Group 2: Good clinical evidence of efficacy & safety, limited access

Some may require a prescription, for example.

Read more

Group 3: Limited clinical evidence of efficacy but good safety, used in leading integrative programs

Read more

Group 4: Limited clinical evidence of efficacy, or significant cautions, but potential significant benefit

May be used in leading integrative oncology programs. Therapies in this group may need more medical oversight and surveillance.

Read more

Group 5: Especially promising preclinical evidence of efficacy and safety

Read more

Group 6: Evidence of no efficacy or may be dangerous

Read more

Diets and Metabolic Approaches

Read more

Therapies using Heat, Sound, Light or Cutting-edge Radiotherapy

Read more

Managing Side Effects and Promoting Wellness

Managing or relieving side effects or symptoms, reducing treatment toxicity, supporting quality of life or promoting general well-being

Natural Products

Group 1: Good clinical evidence of efficacy & safety, easy access

These therapies may be widely used in integrative cancer protocols and traditional medical systems.

Read more

Group 2: Good clinical evidence of efficacy & safety, limited access

Some may require a prescription, for example.

Read more

Group 3: Limited clinical evidence of efficacy but good safety, used in leading integrative programs

Read more

Group 4: Limited clinical evidence of efficacy, or significant cautions, but potential significant benefit

May be used in leading integrative oncology programs. Therapies in this group may need more medical oversight and surveillance.

Read more

Group 5: Especially promising preclinical evidence of efficacy and safety

Read more

Group 6: Evidence of no efficacy or may be dangerous

Read more

Off-label, Overlooked or Novel Cancer Approaches (ONCAs)

Group 2: Good clinical evidence of efficacy & safety, limited access

Some may require a prescription, for example.

Read more

Group 3: Limited clinical evidence of efficacy but good safety, used in leading integrative programs

Read more

Group 4: Limited clinical evidence of efficacy, or significant cautions, but potential significant benefit

Read more

Mind-Body Approaches

Read more

Manipulative and Body-based Methods

Read more

Energy Therapies

Read more

Bioelectromagnetically Based Therapies

Read more

Reducing Risk

Reducing the risk of developing cancer or the risk of recurrence

Risk Factors

Risk factors for prostate cancer include these:288

Expand list

Conventional Therapies

Read more

Natural Products

Group 1: Good clinical evidence of efficacy & safety, easy access

These therapies may be widely used in integrative cancer protocols and traditional medical systems.

Read more

Group 3: Limited clinical evidence of efficacy but good safety, used in leading integrative programs

Read more

Group 4: Limited clinical evidence of efficacy, or significant cautions, but potential significant benefit

May be used in leading integrative oncology programs. Therapies in this group may need more medical oversight and surveillance.

Read more

Group 5: Especially promising preclinical evidence of efficacy and safety

Other therapies with preclinical evidence only for reducing risk

Read more

Group 6: Evidence of no efficacy or may be dangerous

Read more

Off-label, Overlooked or Novel Cancer Approaches (ONCAs)

Group 2: Good clinical evidence of efficacy & safety, limited access

Some may require a prescription, for example.

Read more

Group 4: Limited clinical evidence of efficacy, or significant cautions, but potential significant benefit

May be used in leading integrative oncology programs. Therapies in this group may need more medical oversight and surveillance.

Read more

Commentary

In his Grand Rounds Urology lecture, Aaron Katz, MD, cites the literature supporting vitamin D’s positive effect in reducing disease risk, including prostate cancer. Dr. Katz’s practice is to “obtain [baseline] vitamin D levels on all of my [prostate cancer] patients that are on active surveillance, whether it be in the recurrent cases or in primary [cases]l. Then. . . restore about 1,000 units of vitamin D, [to] give you just a bump [in blood levels] up of around 10. Most people in the field believe that the therapeutic range is somewhere between 40 and 50. I have not had any problem going straight to 5,000. If you look in the vitamins, if you’re on multivitamins and you look at how much vitamin D is in your vitamin capsule, it’s about 200 units of vitamin D. I will start with 5,000 per day and then repeat the vitamin D [blood test] in three months.”366

BCCT advisor Keith Block, MD, says that off-label use of calcitriol, which is the most active form of vitamin D, is of particular interest in prostate cancer.367

Dr. Block prefers to get at the root of inflammation using diet and other non-drug approaches, but in certain situations, he uses Celebrex to block the COX-2 enzyme, “since the inflammatory chemicals the enzyme spawns play a major role in blocking the effectiveness of chemotherapy and radiation.”368 Note that NSAIDs can have serious, even life-threatening side effects; use them only under medical supervision.369

Written by Laura Pole, RN, MSN, OCNS, and Nancy Hepp, MS; most recent update on May 24, 2019. BCCT is grateful for the KNOW Oncology resource used in creating this summary.

Highlighted Video

Dean Ornish, MD: Symington 2017

Read more

View All References

More Information

Integrative Approaches to Prostate Cancer Care

Conventional Approaches

Advocacy and Support Groups

  • National Comprehensive Cancer Network: Advocacy and Support Groups; select prostate cancer or another topic of interest from the dropdown menu.

More from Our Resources Database

Enter your comments or questions below.

Comments (0)




Allowed tags: <b><i><br>Add a new comment: